Community-acquired necrotizing pneumonia caused by methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a Chinese teenager: Case report and literature review

International Journal of Infectious Diseases

Volumn 26, Issue , 2014, Pages 17-21

  Chen, Jie ^a   Luo, Yanping ^a   Zhang, Shu ^a   Liang, Zhixin ^a   Wang, Ying ^a   Zhang, Ying ^a   Zhou, Guang ^a   Jia, Yanhong ^a   Chen, Liangan ^a   She, Danyang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Community acquired methicillin resistant Staphylococcus aureus; Community acquired pneumonia; Fosfomycin; Linezolid; Panton Valentine leukocidin; Teicoplanin

Indexed keywords

AZITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; FOSFOMYCIN; LINEZOLID; PANTON VALENTINE LEUKOCIDIN; TEICOPLANIN; TIGECYCLINE; BACTERIAL TOXIN; EXOTOXIN; LEUKOCIDIN; PANTON-VALENTINE LEUKOCIDIN;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; CASE REPORT; CHINESE; COMMUNITY ACQUIRED NECROTIZING PNEUMONIA; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COUGHING; DIFFERENTIAL DIAGNOSIS; DYSPNEA; FEMALE; FEVER; HUMAN; MECA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PLEURA FLUID; SHIVERING; SPUTUM ANALYSIS; VITAL SIGN; CHINA; COMMUNITY-ACQUIRED INFECTIONS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PNEUMONIA, BACTERIAL; STAPHYLOCOCCAL INFECTIONS;

ADOLESCENT; BACTERIAL TOXINS; CHINA; COMMUNITY-ACQUIRED INFECTIONS; EXOTOXINS; FEMALE; HUMANS; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA, BACTERIAL; STAPHYLOCOCCAL INFECTIONS;

EID: 84904277730     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.02.025     Document Type: Article

References (30)

1. David M.Z., Daum R.S. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010, 23:616-687.
2. Deleo F.R., Otto M., Kreiswirth B.N., Chambers H.F. Community-associated methicillin-resistant Staphylococcus aureus. Lancet 2010, 375:1557-1568.
3. Nastaly P., Grinholc M., Bielawski K.P. Molecular characteristics of community-associated methicillin-resistant Staphylococcus aureus strains for clinical medicine. Arch Microbiol 2010, 192:603-617.
4. Otter J.A., French G.L. Community-associated meticillin-resistant Staphylococcus aureus: the case for a genotypic definition. J Hosp Infect 2012, 81:143-148.
5. Shallcross L.J., Fragaszy E., Johnson A.M., Hayward A.C. The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis. Lancet Infect Dis 2013, 13:43-54.
6. Karampela I., Poulakou G., Dimopoulos G. Community acquired methicillin resistant Staphylococcus aureus pneumonia: an update for the emergency and intensive care physician. Minerva Anestesiol 2012, 78:930-940.
7. Bassetti M., Nicco E., Mikulska M. Why is community-associated MRSA spreading across the world and how will it change clinical practice?. Int J Antimicrob Agents 2009, 34:S15-S19.
8. Mandell L.A., Wunderink R. Methicillin-resistant Staphylococcus aureus and community-acquired pneumonia: an evolving relationship. Clin Infect Dis 2012, 54:1134-1136.
9. Geng W., Yang Y., Wu D., Zhang W., Wang C., Shang Y., et al. Community-acquired, methicillin-resistant Staphylococcus aureus isolated from children with community-onset pneumonia in China. Pediatr Pulmonol 2010, 45:387-394.
10. Song J.H., Hsueh P.R., Chung D.R., Ko K.S., Kang C.I., Peck K.R., et al. Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study. J Antimicrob Chemother 2011, 66:1061-1069.
11. Otter J.A., French G.L. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis 2010, 10:227-239.
12. Millar B.C., Loughrey A., Elborn J.S., Moore J.E. Proposed definitions of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA). J Hosp Infect 2007, 67:109-113.
13. Mediavilla J.R., Chen L., Mathema B., Kreiswirth B.N. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Curr Opin Microbiol 2012, 15:588-595.
14. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Ray S., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
15. Moran G.J., Krishnadasan A., Gorwitz R.J., Fosheim G.E., Albrecht V., Limbago B., et al. Prevalence of methicillin-resistant Staphylococcus aureus as an etiology of community-acquired pneumonia. Clin Infect Dis 2012, 54:1126-1133.
16. Qiao Y., Dong F., Song W., Wang L., Yang Y., Shen X. Hospital- and community-associated methicillin-resistant Staphylococcus aureus: a 6-year surveillance study of invasive infections in Chinese children. Acta Paediatr 2013, 102:1081-1086.
17. Wu D., Wang Q., Yang Y., Geng W., Wang Q., Yu S., et al. Epidemiology and molecular characteristics of community-associated methicillin-resistant and methicillin-susceptible Staphylococcus aureus from skin/soft tissue infections in a children's hospital in Beijing. China. Diagn Microbiol Infect Dis 2010, 67:1-8.
18. Zhao C., Liu Y., Zhao M., Liu Y., Yu Y., Chen H., et al. Characterization of community acquired Staphylococcus aureus associated with skin and soft tissue infection in Beijing: high prevalence of PVL+ST398. PLoS One 2012, 7:e38577.
19. Li H.T., Zhang T.T., Huang J., Zhou Y.Q., Zhu J.X., Wu B.Q. Factors associated with the outcome of life-threatening necrotizing pneumonia due to community-acquired Staphylococcus aureus in adult and adolescent patients. Respiration 2011, 81:448-460.
20. Coombs G.W., Nimmo G.R., Pearson J.C., Christiansen K.J., Bell J.M., Collignon P.J., et al. Australian Group for Antimicrobial Resistance. Prevalence of MRSA strains among Staphylococcus aureus isolated from outpatients, 2006. Commun Dis Intell Q Rep 2009, 33:10-20.
21. Costello M.E., Huygens F. Diversity of community acquired MRSA carrying the PVL gene in Queensland and New South Wales, Australia. Eur J Clin Microbiol Infect Dis 2011, 30:1163-1167.
22. Geng W., Yang Y., Wu D., Huang G., Wang C., Deng L., et al. Molecular characteristics of community-acquired, methicillin-resistant Staphylococcus aureus isolated from Chinese children. FEMS Immunol Med Microbiol 2010, 58:356-362.
23. Chua K., Laurent F., Coombs G., Grayson M.L., Howden B.P. Antimicrobial resistance: not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy. Clin Infect Dis 2011, 52:99-114.
24. Mendes R.E., Sader H.S., Deshpande L.M., Diep B.A., Chambers H.F., Jones R.N. Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid. J Clin Microbiol 2010, 48:568-574.
25. Larsen A.R., Stegger M., Böcher S., Sørum M., Monnet D.L., Skov R.L. Emergence and characterization of community-associated methicillin-resistant Staphylococcus aureus infections in Denmark, 1999 to 2006. J Clin Microbiol 2009, 47:73-78.
26. Kreienbuehl L., Charbonney E., Eggimann P. Community-acquired necrotizing pneumonia due to methicillin-sensitive Staphylococcus aureus secreting Panton-Valentine leukocidin: a review of case reports. Ann Intensive Care 2011, 1:52.
27. Lobo L.J., Reed K.D., Wunderink R.G. Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumonia. Chest 2010, 138:130-136.
28. Nathwani D., Morgan M., Masterton R.G., Dryden M., Cookson B.D., French G., et al. British Society for Antimicrobial Chemotherapy Working Party on Community-onset MRSA Infections. Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 2008, 61:976-994.
29. Wunderink R.G. How important is methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia and what is best antimicrobial therapy?. Infect Dis Clin North Am 2013, 27:177-188.
30. Liu C., Bayer A., Cosgrove S.E., Daum R.S., Fridkin S.K., Gorwitz R.J., et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011, 52:e18-e55.